Buchou, C.; Laud-Duval, K.; van der Ent, W.; Grossetête, S.; Zaidi, S.; Gentric, G.; Corbé, M.; Müller, K.; Del Nery, E.; Surdez, D.;
et al. Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins. Cancers 2022, 14, 2327.
https://doi.org/10.3390/cancers14092327
AMA Style
Buchou C, Laud-Duval K, van der Ent W, Grossetête S, Zaidi S, Gentric G, Corbé M, Müller K, Del Nery E, Surdez D,
et al. Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins. Cancers. 2022; 14(9):2327.
https://doi.org/10.3390/cancers14092327
Chicago/Turabian Style
Buchou, Charlie, Karine Laud-Duval, Wietske van der Ent, Sandrine Grossetête, Sakina Zaidi, Géraldine Gentric, Maxime Corbé, Kévin Müller, Elaine Del Nery, Didier Surdez,
and et al. 2022. "Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins" Cancers 14, no. 9: 2327.
https://doi.org/10.3390/cancers14092327
APA Style
Buchou, C., Laud-Duval, K., van der Ent, W., Grossetête, S., Zaidi, S., Gentric, G., Corbé, M., Müller, K., Del Nery, E., Surdez, D., & Delattre, O.
(2022). Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins. Cancers, 14(9), 2327.
https://doi.org/10.3390/cancers14092327